What is syphilis and why does the trend matter
Syphilis is a bacterial sexually transmitted infection caused by Treponema pallidum. After several decades of historically low levels in many high-income countries, syphilis rates began rising noticeably in the late 2010s and early 2020s. The increase is not uniform: it is concentrated among men who have sex with men, people who inject drugs, and pregnant people, where it can cause stillbirth, neonatal death, and congenital syphilis. Public‑health officials emphasize that syphilis remains curable, but rising rates reveal gaps in testing, care linkage, and prevention infrastructure that can persist over time.
Core drivers behind rising syphilis rates
Multiple overlapping factors explain the upward trend, including behavioral, structural, and surveillance changes. These drivers interact differently across populations and regions, so no single cause explains every setting. Key contributors include:
- Condomless sex networks with higher partner turnover and limited STI awareness within some social networks.
- Competing public‑health priorities and workforce shortages that reduced routine STI screening and partner services.
- Stigma and structural barriers that discourage care-seeking, particularly among marginalized men who have sex with men and people who inject drugs.
- Disruptions to care during the COVID-19 pandemic, including postponed testing and treatment and decoupling from usual care settings.
- Illicit drug market dynamics and unstable housing that increase vulnerability and limit access to consistent prevention services.
How surveillance and reporting shape perceived increases
Changes in how and how often we look for syphilis can make rates appear to rise even if transmission has not changed as quickly. Improvements in reporting completeness, electronic case reporting, and broader use of quantitative tests can inflate counts in the short term. Shifts in testing location, such as moving from clinical to community-based and emergency department testing, may also affect which cases are captured. Importantly, true increases in incidence and prevalence are measured after adjusting for these reporting effects, and analyses generally confirm genuine upward trends in many settings.
Surveillance influences on measured rates
| Factor | Potential impact on reported rates | Evidence type |
|---|---|---|
| Expanded laboratory testing and electronic case reporting | Higher case counts due to detection of previously missed infections | Methodological |
| Shift from clinical to community-based testing | Different case mix; may increase detection in some populations | Observational |
| Pandemic-driven care disruptions | Short-term dips in testing followed by rebounds that can appear as spikes | Evaluative (early pandemic) |
Notable demographic and geographic patterns
In several countries, including the United States and parts of Europe, increases are most pronounced among men who have sex with men. Rising congenital syphilis has been especially concerning, reflecting delayed diagnosis and treatment in pregnancy or missed prenatal care. Certain racial and ethnic groups experience higher rates of congenital syphilis, often due to structural inequities that affect access to prenatal care. Some regions also report increases among people who inject drugs, particularly where syphilis and stimulant drug use intersect, and among people experiencing homelessness or unstable housing. Localized outbreaks can emerge when a highly transmissible strain circulates through dense sexual or drug-use networks with limited healthcare access.
Public‑health responses and what works
Addressing rising syphilis requires layered strategies, not single interventions. Core public‑health tools include frequent and targeted screening, rapid partner notification (also called contact tracing), and expedited partner therapy where permitted and appropriate. Integrating STI services into settings where at‑risk populations already receive care can improve detection and reduce reinfection. For pregnant people, early and repeat prenatal screening is essential to prevent congenital syphilis. Community outreach, peer navigation, and culturally competent messaging can reduce stigma and link people to care. Emerging concerns about antibiotic resistance are currently minimal, but they underscore the need for responsible use and ongoing monitoring of treatment outcomes.
Prevention fundamentals and practical steps
Prevention relies on a combination of behavioral strategies, structural supports, and clinical tools. Consistent condom use and reducing partner concurrency lower risk in networks where condoms are feasible. Regular STI screening tailored to personal risk can catch infection early, before complications or onward transmission occur. Needle‑exchange programs and other harm‑reduction services reduce risk among people who inject drugs. Pre‑exposure prophylaxis (PrEP) does not protect against syphilis, so dual protection through condoms and regular testing remains important for sexually active people at risk. Open communication with partners about STI status and testing history supports shared prevention decisions.
Outlook and long‑term considerations
Syphilis trends are sensitive to changes in public‑health capacity, social determinants of health, and how services are delivered. Sustained funding for local health departments, community health workers, and outreach programs can help keep detection and linkage strong. Maintaining high prenatal screening coverage is especially important to prevent congenital cases. Continued genomic surveillance for treatment‑failure mutations and emerging resistance will inform clinical guidance. For individuals, periodic risk assessment, routine screening aligned with personal behavior, and timely treatment remain the most reliable ways to reduce both personal risk and population-level transmission over the long term.